首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
Growing concerns over the safety and efficacy of anti-depressant drugs prescribed to children have caught the eye of Congress an
Growing concerns over the safety and efficacy of anti-depressant drugs prescribed to children have caught the eye of Congress an
admin
2010-05-14
59
问题
Growing concerns over the safety and efficacy of anti-depressant drugs prescribed to children have caught the eye of Congress and the New York state attorney general. Now they’re becoming the catalyst for calls to reform the way clinical trials of all drugs are reported.
Pressure is already causing some changes within the pharmaceutical industry. And it has put the US Food and Drug Administration (FDA), which approves new drugs, in the hot seat. If reforms are carried out, they could bring an unprecedented level of transparency to drug research.
The solution now under consideration: a public database, or registry, of drug trials, where companies would post the results of those trials.
In congressional testimony Thursday, a spokesman for the American Medical Association endorsed the registry and said it should include information on each trial’ s purpose and objective, its design, and the dates it begins and ends. If the trial is not completed, the registry should include an explanation.
While drug companies have been eager to make public any positive results of their trials, recent revelations suggest they’ ye balked at divulging tests when the results are not what they’ d hoped to see. The furor has centered around the use of anti- depressants on children.
The industry has begun to make some moves to address the concerns about drug trials. Drug companies have agreed to set up a voluntary system of posting their drug trials on the Intemet. But that seems unlikely to satisfy some members of Congress, who are expected to introduce legislation to establish a mandatory drug registry.
Last week, editors of a dozen influential medical journals announced that they would begin requiring drug companies to post a drug trial in a public database prior to accepting an article about it. Doctors rely on these articles to make treatment choices. The editors hope that the registry will force unfavorable drug studies, before kept secret, into the open.
Medical journals already had been tightening up on the authorship of their articles, insisting that authors declare if they had any conflicts of interest, such as any financial or other ties to the drug company, says Daniel Callahan, a director at the Hastings Center, a nonprofit bioethics research institute in Garrison, N.Y.
Information from previously undisclosed clinical trials could lower prices, reduce the number of badly designed trials, and help doctors considering the use of a drug for a non-approved purpose to know why it hasn’t been approved for that use.
Antidepressant drugs "have some serious side effects... that seem to be much more common than people realize... much more common than you might think from seeing drug ads and from reports on drug studies," says Joel Gurin, executive vice president of Consumer Reports. His magazine just finished a survey of readers showing a "dramatic shift from talk therapy to drug therapy for mental health problems" during the past decade. In 1995, less than half of people getting mental health treatment—40 percent—got drug therapy. Today 68 percent receive drug treatment, Mr. Gurin says.
Some studies coming to light show that antidepressants work no better than placebos. Even better than merely registering drug trials, Caplan (director of the Center for Bioethics at the University of Pennsylvania in Philadelphia) suggests, would be to require that a new drug not only be "safe and do what it’ s sup posed to do", but that it do it as well or better than other drugs already on the market. That, he says, would help push research into new areas and save money.
New measures of Medical journals does NOT aim at ______.
选项
A、helping doctors to make right treatment choices
B、enhancing the transparency of drug studies
C、stopping unfavorable drug studies from being kept back
D、lowering prices of drugs
答案
D
解析
医学期刊采取新的措施,其目的不包括下列哪一项?第七段讲到具体内容,其目的应包括 A,B,C项。
转载请注明原文地址:https://kaotiyun.com/show/upqO777K
0
专业英语八级
相关试题推荐
Listeningisoneofthefirstthingswelearntodoandoneofthethingswedomost.Theaveragepersonspends【C1】______ofthei
Historycastsalongshadow.Manyofthefirstbacteriatobediscoveredwereagentsofdisease,andthatishowmostpeopleper
Modernintelligencetestingbeganin【B1】______.FrenchpsychologistBinetbasedhistestonthetheorythatintelligenceincreas
Evenaspharmaceuticalcompaniespouredarecordamountofmoneyintodrugdevelopmentin2005,theindustry’sresearchdrought
ForquiteafewyearswehavebeentalkingaboutaddictiontotheInternet.Nowweareputtingtogether【C1】______thosestudents
Whoseworkswouldyoumostprobablychoosetoreadifyouwereinterestedinsatire?WhichofthefollowingwriterswasaNobel
"Givemelibertyorgivemedeath."Thisisafamousstatementmadeby_____,awellknownfigureinU.S.history.
A、Anexportsalesmanworkingoverseas.B、Anaccountantworkinginthecompany.C、Aproductionmanagerinabranch.D、Apolicyma
Toseehowbigcarrierscouldcontroltheonlineworld,youmustunderstanditsstructures.EarthlinkgivesJenniferaccesst
随机试题
甲状腺大部切除术后,一般不会出现
A.我国研制了抗肿瘤新药放线菌素DB.大量筛选抗肿瘤新药,合成了氟脲嘧啶C.我国研制了三尖杉碱D.我国实施药品法E.我国颁发《药品临床试验管理规范(试行)》发生于20世纪40~50年代
A.猪瘟B.猪伪狂犬C.猪乙型脑炎D.猪细小病毒E.猪繁殖与呼吸综合征初胎母猪出现流产、木乃伊胎和死胎,但不表现出其他临床症状。经产母猪无异常表现。该病可能是
在牙周治疗中若全身应用甲硝唑,下列提法不正确的是
药物在体内某部位的转运速度与该部位的血药浓度的一次方成正比药物浓度较高而出现酶活力饱和时的速度过程
班主任工作的中心任务是()。
母亲的年龄是儿子年龄的四倍,三年前母子年龄之和是49岁,则母亲现在的年龄是多少岁?()
在美国,癌症病人的平均生存年限(即从确诊为癌症到死亡的年限)是7年。而在亚洲,癌症病人的平均生存年限只有4年。因此。美国在延长癌症病人生命方面的医疗水平要高于亚洲。以下哪项如果为真,最能削弱上述论证?
ThedivorcerateinAmericahasreached____________________________________
Thecrisishas【C1】______questionsaboutthelargeoilcompaniesandwindfallprofits.Criticsoftheoilindustry【C2】______
最新回复
(
0
)